Header Logo

Aniket Kawatkar

Concepts (144)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
5
2015
22
1.450
Why?
Managed Care Programs
6
2017
313
1.160
Why?
Health Expenditures
3
2014
70
0.900
Why?
Diverticulitis, Colonic
2
2014
8
0.880
Why?
Middle Aged
20
2021
7976
0.620
Why?
Emergency Service, Hospital
4
2021
377
0.620
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2018
41
0.570
Why?
Data Collection
3
2014
252
0.560
Why?
Algorithms
2
2020
237
0.560
Why?
Febrile Neutropenia
1
2017
3
0.560
Why?
Attention Deficit Disorder with Hyperactivity
2
2014
64
0.540
Why?
Antirheumatic Agents
3
2015
11
0.530
Why?
Retrospective Studies
12
2021
2471
0.530
Why?
Asthma
2
2016
385
0.500
Why?
Adrenergic beta-2 Receptor Agonists
1
2015
6
0.500
Why?
Aged
17
2021
6150
0.500
Why?
Male
19
2021
10094
0.490
Why?
Female
19
2021
12729
0.480
Why?
Tomography, X-Ray Computed
2
2014
211
0.480
Why?
Diverticulitis
1
2014
2
0.470
Why?
Humans
22
2021
17707
0.460
Why?
Electronic Health Records
3
2020
694
0.450
Why?
Inpatients
1
2014
81
0.440
Why?
Outpatients
1
2014
107
0.440
Why?
Consumer Behavior
2
2004
27
0.440
Why?
Health Care Costs
1
2015
222
0.430
Why?
Ambulatory Care
1
2014
241
0.410
Why?
Mental Health
1
2014
161
0.410
Why?
Young Adult
8
2015
2450
0.410
Why?
Adolescent
9
2015
3671
0.400
Why?
Self Report
1
2014
252
0.390
Why?
Adult
12
2016
7658
0.370
Why?
Severity of Illness Index
1
2012
448
0.350
Why?
Patient Acceptance of Health Care
1
2014
387
0.350
Why?
Acute Coronary Syndrome
2
2021
18
0.350
Why?
Breast Neoplasms
1
2018
956
0.340
Why?
California
9
2019
2327
0.330
Why?
Acute Disease
3
2014
141
0.320
Why?
Aged, 80 and over
7
2019
1927
0.320
Why?
Comorbidity
4
2015
590
0.310
Why?
Urinary Bladder Neoplasms
2
2019
58
0.300
Why?
Cohort Studies
6
2020
2589
0.280
Why?
Cost-Benefit Analysis
2
2020
243
0.250
Why?
United States
6
2015
3914
0.250
Why?
Drug Information Services
1
2004
3
0.230
Why?
Drug Industry
1
2004
4
0.220
Why?
Formularies as Topic
1
2004
2
0.220
Why?
Leukocytosis
2
2014
5
0.220
Why?
Advertising as Topic
1
2004
23
0.220
Why?
Abdominal Pain
2
2014
15
0.220
Why?
Insurance, Pharmaceutical Services
1
2004
25
0.220
Why?
Predictive Value of Tests
2
2014
355
0.220
Why?
Treatment Outcome
3
2018
1254
0.210
Why?
Fever
2
2014
55
0.210
Why?
Critical Pathways
1
2021
11
0.180
Why?
Odds Ratio
4
2015
670
0.180
Why?
Sex Factors
3
2021
639
0.170
Why?
Radiotherapy, Intensity-Modulated
1
2020
2
0.170
Why?
Tonsillar Neoplasms
1
2020
2
0.170
Why?
Robotic Surgical Procedures
1
2020
6
0.170
Why?
Exercise Test
1
2020
45
0.170
Why?
Urinary Bladder
1
2019
10
0.160
Why?
Hospitalization
2
2017
805
0.160
Why?
BCG Vaccine
1
2019
7
0.160
Why?
Adjuvants, Immunologic
1
2019
16
0.160
Why?
Carcinoma, Squamous Cell
1
2020
55
0.160
Why?
Cardiovascular Diseases
2
2015
596
0.150
Why?
Antineoplastic Agents
1
2019
60
0.150
Why?
Recurrence
2
2016
189
0.150
Why?
Incidence
3
2017
1269
0.150
Why?
Risk Assessment
2
2021
1106
0.150
Why?
Disease Progression
2
2016
266
0.150
Why?
Mastectomy, Segmental
1
2018
20
0.150
Why?
Health Status Disparities
1
2019
147
0.150
Why?
Mastectomy
1
2018
36
0.140
Why?
Logistic Models
3
2015
918
0.140
Why?
Comparative Effectiveness Research
1
2018
66
0.140
Why?
Quality of Health Care
1
2019
276
0.140
Why?
Blood Cells
1
2016
4
0.130
Why?
Eosinophils
1
2016
9
0.130
Why?
Age Factors
2
2019
918
0.130
Why?
Delivery of Health Care, Integrated
3
2019
531
0.130
Why?
Population Surveillance
2
2015
265
0.130
Why?
Multivariate Analysis
2
2014
561
0.130
Why?
Registries
1
2018
470
0.120
Why?
Medication Adherence
2
2015
245
0.120
Why?
Etanercept
1
2015
4
0.120
Why?
International Classification of Diseases
1
2015
85
0.120
Why?
Adalimumab
1
2015
5
0.120
Why?
Hip Fractures
1
2015
70
0.120
Why?
Pilot Projects
1
2014
215
0.110
Why?
Patient Preference
1
2014
48
0.110
Why?
Dopamine Uptake Inhibitors
1
2013
4
0.110
Why?
Bupropion
1
2013
12
0.110
Why?
Quinoxalines
1
2013
12
0.110
Why?
Sentinel Surveillance
1
2013
12
0.110
Why?
Nicotinic Agonists
1
2013
26
0.110
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2015
172
0.110
Why?
Benzazepines
1
2013
24
0.100
Why?
Economics, Pharmaceutical
1
2012
2
0.100
Why?
Home Care Agencies
1
2012
2
0.100
Why?
Prognosis
1
2014
613
0.100
Why?
Abscess
1
2012
6
0.100
Why?
Continental Population Groups
1
2014
301
0.100
Why?
Product Surveillance, Postmarketing
1
2013
95
0.100
Why?
Drug Costs
1
2012
34
0.100
Why?
Office Visits
1
2012
77
0.100
Why?
Ethnic Groups
1
2015
474
0.100
Why?
Smoking Cessation
1
2013
193
0.090
Why?
Models, Statistical
1
2012
177
0.090
Why?
Socioeconomic Factors
1
2012
626
0.090
Why?
Risk Factors
2
2014
3367
0.090
Why?
United States Food and Drug Administration
2
2013
34
0.080
Why?
Time Factors
1
2012
1095
0.080
Why?
Neoplasm Staging
2
2020
331
0.080
Why?
Hispanic Americans
2
2019
397
0.060
Why?
European Continental Ancestry Group
2
2019
523
0.060
Why?
Periodicals as Topic
1
2004
14
0.060
Why?
Texas
1
2004
35
0.060
Why?
Attitude
1
2004
30
0.050
Why?
Guidelines as Topic
1
2004
40
0.050
Why?
African Americans
2
2019
465
0.050
Why?
Health Services Research
1
2004
213
0.050
Why?
Follow-Up Studies
2
2016
1218
0.050
Why?
Markov Chains
1
2020
22
0.040
Why?
Cross-Sectional Studies
1
2004
1322
0.040
Why?
Administration, Intravesical
1
2019
2
0.040
Why?
Sensitivity and Specificity
1
2020
304
0.040
Why?
Neoplasm Invasiveness
1
2019
80
0.040
Why?
Natural Language Processing
1
2020
58
0.040
Why?
Cell Count
1
2016
10
0.030
Why?
Practice Patterns, Physicians'
1
2019
324
0.030
Why?
Anti-Asthmatic Agents
1
2016
85
0.030
Why?
Biomarkers
1
2016
312
0.030
Why?
Dose-Response Relationship, Drug
1
2015
128
0.030
Why?
Risk
1
2015
517
0.030
Why?
Varenicline
1
2013
13
0.030
Why?
Health Behavior
1
2015
360
0.030
Why?
Tobacco Use Disorder
1
2013
49
0.030
Why?
Prospective Studies
1
2016
1287
0.030
Why?
Case-Control Studies
1
2015
1117
0.030
Why?
Drug Prescriptions
1
2013
151
0.020
Why?
Medicaid
1
2013
188
0.020
Why?
Prevalence
1
2014
882
0.020
Why?
Concepts (144)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente